"Designing Growth Strategies is in our DNA"

U.S. Blood Transfusion Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments and Reagents & Kits), By Application (Blood Screening, Blood Group Typing) and By End-user (Hospital-based Laboratories and Independent Laboratories & Blood Banks), 2022-2029

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI107024

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Blood Donations Statistics, U.S., 2021
    2. New Product Launches
    3. Key Industry Developments
    4. Prevalence of Key Bleeding Disorders, U.S., 2021
    5. Insights: Blood Donation and Blood Group Type
    6. Blood Group Distribution among Blood Donors in U.S.
    7. Distribution of Blood Group Type, U.S. Population, 2021
    8. Blood Transfusion Statistics, U.S., 2021
    9. Impact of COVID-19 on U.S. Blood Transfusion Diagnostics Market
    10. Overview: Technological Advancements in Blood Transfusion Diagnostics
  5. U.S. Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2018-2028
    1. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Application
      1. Blood Screening
      2. Blood Group Typing
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospital-based Laboratories
      2. Independent Laboratories & Blood Banks
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2021)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Abbott
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Grifols, S.A.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. QuidelOrtho Corporation
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Immucor, Inc.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Bio-Rad Laboratories, Inc.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. F. Hoffmann-La Roche Ltd.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. QUOTIENT LIMITED
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Beckman Coulter, Inc.
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Merck KGaA
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Other Prominent Players
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 1: U.S. Blood Transfusion Diagnostics Market Value Share (%), By Product, 2021 & 2029

Figure 2: U.S. Blood Transfusion Diagnostics Market Value Share (%), By Application, 2021 & 2029

Figure 3: U.S. Blood Transfusion Diagnostics Market Value Share (%), By End-user, 2021 & 2029

Figure 4: U.S. Blood Transfusion Diagnostics Market Share (%), 2021

Table 1: U.S. Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Product, 2018–2029

Table 2: U.S. Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2018–2029

Table 3: U.S. Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By End-user, 2018–2029

  • 2018-2029
  • 2021
  • 2018-2020
  • 106
Consulting Services
    How will you benefit from our consulting services ?